Sign Up Today and Learn More About Genapsys Stock
Invest in or calculate the value of your shares in Genapsys or other pre-IPO companies through EquityZen's platform.
Genapsys Stock (GENA)
DNA Sequencing Technology
GenapSys is a medical technology company that develops low-cost DNA sequencers. With its sequencing technology, the company aims to help support the control and limit the spread of current and future outbreaks. The device can run off of a standard power source and is small enough to fit in the back of a truck or be deployed at hospitals, airports, and public transportation hubs for quick results on virus samples. GenapSys was founded in 2010 and is headquartered in Redwood City, California.
About Genapsys Stock
Founded
2010
Headquarters
Redwood City, CA, US
Total Funding
202M
Industries
Software, Artificial Intelligence, Data and Analytics
GenapSys is a sequencing technology company that aims to help support the control and limit the spread of current and future outbreaks. The company's main goal is to transform research and diagnostics with an affordable, scalable genomic sequencing ecosystem.
In July 2022, Genapsys filed for Chapter 11 bankruptcy.
GenapSys was founded in 2010 and is headquartered in Redwood City, California. Notable investors include Decheng Capital, Oxford Finance Corporation, and Farallon Capital Management.Â
Genapsys Press Mentions
Stay in the know about the latest news on Genapsys
Methods and systems for nucleic acid amplification and sequencing
patents • Apr 14, 2024
Methods and systems for nucleic acid processing
patents • Apr 14, 2024
Third Generation Sequencing Market to Hit $23.92 Billion ...
globenewswire • Jan 26, 2024
With Resolution Bio Acquisition, Exact Sciences Takes Aim at ...
genomeweb • Dec 20, 2023
Next-Generation Sequencing (NGS) Market Size 2023-2028 ...
digitaljournal • Dec 20, 2023
Investors in Genapsys
Discover investors in Genapsys stock and explore their portfolio companies
Genapsys Management
Leadership team at Genapsys
Chief Executive Officer
Jason Myers
Chief Financial Officer
Britton Russell
Join now and verify your accreditation status to gain access to:
- Genapsys current valuation
- Genapsys stock price
- Available deals in Genapsys and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Genapsys stock?
Accredited investors can buy pre-IPO stock in companies like Genapsys through EquityZen funds. These investments are made available by existing Genapsys shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Genapsys stock?
Shareholders can sell their Genapsys stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
